Virtus Investment Advisers’s Idexx Laboratories IDXX Stock Holding History

Virtus Investment Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.53M	Sell	2,731 -276	-9%	-$177K	0.42%	114
2025 Q4	$2.03M	Sell	3,007 -224	-7%	-$153K	0.55%	40
2025 Q3	$2.06M	Buy	+3,231	New	+$1.96M	0.59%	19
2018 Q1	–	Sell	-1,706	Closed	-$267K	–	217
2017 Q4	$267K	Sell	1,706 -182	-10%	-$28.6K	0.03%	365
2017 Q3	$293K	Sell	1,888 -179	-9%	-$28.3K	0.03%	367
2017 Q2	$334K	Sell	2,067 -366	-15%	-$59.4K	0.03%	367
2017 Q1	$376K	Buy	+2,433	New	+$335K	0.03%	348

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus Investment Advisers's IDXX Position: Q1 2026 in Review

Virtus Investment Advisers reduced its Idexx Laboratories (IDXX) stake by 9.2% in Q1 2026, selling an estimated $177K and leaving 2,731 shares worth $1.53M. The position accounts for 0.42% of the portfolio, ranked #114.

Virtus Investment Advisers first reported a position in IDXX in Q1 2017 and has held it in 7 quarters since. The position peaked at $2.06M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Virtus Investment Advisers held 2,731 shares of Idexx Laboratories worth $1.53M as of Q1 2026.
Virtus Investment Advisers sold 276 Idexx Laboratories shares in Q1 2026, an estimated $177K.
Idexx Laboratories made up 0.42% of Virtus Investment Advisers's portfolio in Q1 2026, its #114 holding.
Virtus Investment Advisers first reported a position in Idexx Laboratories in Q1 2017 and has held it in 7 quarters since.
Virtus Investment Advisers's Idexx Laboratories position peaked at $2.06M in Q3 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.